Blood and Laboratory Solutions Licensed by German University
|
By LabMedica International staff writers Posted on 22 Apr 2009 |
|
A German University clinic has licensed a blood information system and laboratory information system for its blood center.
EdgeBlood is the leading Blood Center management system used in France. It is also used to process more than half the blood drawn in Germany as well as processing significant parts of the Austrian and Swiss blood supplies. EdgeBlood is used in Greece as well as five African countries. EdgeBlood has an easy-to-use Windows graphical user interface and contains all major functionality needed by a blood center from donor recruitment through product distribution.
EdgeLab has become the leading Laboratory Information Management System (LIMS) in Europe and is used in more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software packages. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multisite hospital laboratories, as well as small, single site hospitals.
GLI (Alzey, Germany) is the German division of Global Med Technology's Inlog subsidiary. The two systems, EdgeBlood and EdgeLab, have been licensed by the University of Saarland Clinic Blood Center (Homburg, Germany) from GLI. The systems will be deployed on 25 workstations in the blood center and laboratory. Up to 50 remote users will access the Web result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's Laboratory Information System. The blood center collects 30,000 whole blood donations per year.
"After detailed market research, the University Medical Center of Saarland has decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This decision was made because, among other reasons, the system can completely control the management of all essential services in transfusion medicine. Moreover, the software is already in use in the National German Red Cross Blood Donation Services. It has also been used successfully in comparable university facilities for many years. In view of the connection between pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and EdgeLab will create a center of excellence for the University Medical Center of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical Center of Saarland.
Related Links:
GLI
University of Saarland Clinic Blood Center
EdgeBlood is the leading Blood Center management system used in France. It is also used to process more than half the blood drawn in Germany as well as processing significant parts of the Austrian and Swiss blood supplies. EdgeBlood is used in Greece as well as five African countries. EdgeBlood has an easy-to-use Windows graphical user interface and contains all major functionality needed by a blood center from donor recruitment through product distribution.
EdgeLab has become the leading Laboratory Information Management System (LIMS) in Europe and is used in more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software packages. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multisite hospital laboratories, as well as small, single site hospitals.
GLI (Alzey, Germany) is the German division of Global Med Technology's Inlog subsidiary. The two systems, EdgeBlood and EdgeLab, have been licensed by the University of Saarland Clinic Blood Center (Homburg, Germany) from GLI. The systems will be deployed on 25 workstations in the blood center and laboratory. Up to 50 remote users will access the Web result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's Laboratory Information System. The blood center collects 30,000 whole blood donations per year.
"After detailed market research, the University Medical Center of Saarland has decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This decision was made because, among other reasons, the system can completely control the management of all essential services in transfusion medicine. Moreover, the software is already in use in the National German Red Cross Blood Donation Services. It has also been used successfully in comparable university facilities for many years. In view of the connection between pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and EdgeLab will create a center of excellence for the University Medical Center of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical Center of Saarland.
Related Links:
GLI
University of Saarland Clinic Blood Center
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Hepatitis B Assay
Monolisa HBs Ag ULTRA Assay
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune... Read more
First-of-its-Kind Blood Test Detects Trauma-Related Diseases
In today’s fast-paced world, stress and trauma have unfortunately become common experiences for many individuals. Continuous exposure to stress hormones can confuse the immune system, causing it to misinterpret... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
